CAS 22298-29-9
:betamethasone 17-benzoate
Description:
Betamethasone 17-benzoate is a synthetic corticosteroid with anti-inflammatory and immunosuppressive properties. It is derived from betamethasone, a potent glucocorticoid, and is characterized by the presence of a benzoate ester at the 17-position. This modification enhances its lipophilicity, allowing for improved skin penetration and prolonged action when used in topical formulations. The compound is typically a white to off-white crystalline powder, and it is soluble in organic solvents such as ethanol and acetone, but has limited solubility in water. Betamethasone 17-benzoate is commonly used in dermatological preparations to treat various skin conditions, including eczema, psoriasis, and dermatitis, due to its ability to reduce inflammation and suppress immune responses. Its pharmacological effects are mediated through the modulation of gene expression, leading to decreased production of pro-inflammatory cytokines. As with other corticosteroids, its use should be carefully monitored to avoid potential side effects, including skin atrophy and systemic absorption, especially with prolonged use.
Formula:C29H33FO6
InChI:InChI=1/C29H33FO6/c1-17-13-22-21-10-9-19-14-20(32)11-12-26(19,2)28(21,30)23(33)15-27(22,3)29(17,24(34)16-31)36-25(35)18-7-5-4-6-8-18/h4-8,11-12,14,17,21-23,31,33H,9-10,13,15-16H2,1-3H3/t17-,21-,22-,23-,26-,27-,28-,29-/m0/s1
InChI key:InChIKey=SOQJPQZCPBDOMF-YCUXZELOSA-N
SMILES:O(C(=O)C1=CC=CC=C1)[C@@]2(C(CO)=O)[C@]3(C)[C@@](C[C@@H]2C)([C@]4([C@](F)([C@@H](O)C3)[C@]5(C)C(CC4)=CC(=O)C=C5)[H])[H]
Synonyms:- (11Beta,16Beta)-9-Fluoro-11,21-Dihydroxy-16-Methyl-3,20-Dioxopregna-1,4-Dien-17-Yl Benzoate
- (11β,16β)-17-(Benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
- (8Xi,10Xi,11Beta,13Xi,16Beta)-9-Fluoro-11,21-Dihydroxy-16-Methyl-3,20-Dioxopregna-1,4-Dien-17-Yl Benzoate
- Bebate
- Beben
- Benisone
- Betamethasone Benzoate
- Euvaderm
- Flurobate
- Ms 1112
- Parbetan
- Pregna-1,4-diene-3,20-dione, 17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl-, (11β,16β)-
- Pregna-1,4-diene-3,20-dione, 9-fluoro-11β,17,21-trihydroxy-16β-methyl-, 17-benzoate
- Uticort
- W 5975
- Betamethasone 17-benzoate
- BETAMETHASONE BENZOATE (200 MG)
- betamethasone17-benzoate
- betamethasonebenzoate
- 16-beta)-(11-beta
- pregna-1,4-diene-3,20-dione,17-(benzoyloxy)-9-fluoro-11,21-dihydroxy-16-methyl
- 17-Benzoate
- 17-Benzoyloxy-9-fluoro-11β,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione
- BETAMETHASONE BENZOATE USP(CRM STANDARD)
- (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Betamethasone Benzoate
CAS:Halogenated derivatives of adrenal cortical hormonesFormula:C29H33FO6Color and Shape:White PowderMolecular weight:496.22612Betamethasone 17-benzoate
CAS:<p>Betamethasone 17-benzoate is a representative steroid. It also can be used in the treatment of recurrent aphothous ulcers (RAU).</p>Formula:C29H33FO6Purity:98%Color and Shape:SolidMolecular weight:496.57Betamethasone 17-benzoate
CAS:Controlled Product<p>Betamethasone 17-benzoate is a synthetic corticosteroid with antiinflammatory and antipruritic properties. It is available in the form of an ointment, cream, or lotion. Betamethasone 17-benzoate has been shown to be effective in the treatment of inflammatory bowel disease and leishmania. Betamethasone binds to the glucocorticoid receptor and inhibits the production of prostaglandins involved in inflammation. This drug also has a low potency, which means that it takes more time for this drug to have an effect on the body.</p>Formula:C29H33FO6Purity:Min. 95%Molecular weight:496.6 g/mol




